4 Pharmaceuticals Stocks to Buy Now

Advertisement

The grades of 4 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

The rating of Medicines Company (MDCO) moves up this week, rising from a C to a B. Medicines Company develops products that improve specialized care. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of MDCO stock.

This week, Aerie Pharmaceuticals, Inc. (AERI) pushes up from a C to a B rating. For more information, get Portfolio Grader’s complete analysis of AERI stock.

Lipocine, Inc.’s (LPCN) ratings are looking better this week, moving up to a A from last week’s B. Lipocine, Inc. is engaged in the development of pharmaceutical products in the areas of men’’s and women’’s health. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of LPCN stock.

MediWound Ltd. (MDWD) boosts its rating from a C to a B this week. The company also gets A’s in sales growth, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of MDWD stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/02/4-pharmaceuticals-stocks-to-buy-now-2/.

©2024 InvestorPlace Media, LLC